Doctors must look at no matter if their clients with fundamental NAION danger factors can be adversely impacted by utilization of PDE5 inhibitors. People who have already skilled NAION are at elevated danger of NAION recurrence. Thus, PDE5 inhibitors, including LEVITRA, really should be utilized with warning in these people and only in the event th